Lots of implications in this update. "The RVA
Post# of 9122
(Total Views: 469)
Posted On: 03/10/2021 12:31:36 AM
Re: nmbr1stckpckr #8059
Lots of implications in this update.
"The RVA development research is currently focused upon adaptation to a cartridge format that will provide ease of use and affordability."
Is this in-house or with a partner? My guess is with a partner being that we all know the very limited resources of the Company. Who's the partner?
The three milestones are great achievements as they prove all the claims made when the idea was announced for this new test!
And ironically, must thank whoever it was who reported
the Company to the SEC, FINRA and the FDA. The Company survived the investigations unscathed so we know that the developments detailed in this update is REAL!
"The RVA development research is currently focused upon adaptation to a cartridge format that will provide ease of use and affordability."
Is this in-house or with a partner? My guess is with a partner being that we all know the very limited resources of the Company. Who's the partner?
The three milestones are great achievements as they prove all the claims made when the idea was announced for this new test!
And ironically, must thank whoever it was who reported
the Company to the SEC, FINRA and the FDA. The Company survived the investigations unscathed so we know that the developments detailed in this update is REAL!
(1)
(1)Nanologix Inc (NNLX) Stock Research Links
Scroll down for more posts ▼